StockNews.AI
SNN
StockNews.AI
197 days

Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes

1. Smith+Nephew launches Combat Sports Medicine Course in February 2025. 2. Popularity of combat sports has surged; 6.6M participants in the U.S. 3. Course chaired by Dr. Michael Banffy aims to address sports injury management. 4. Smith+Nephew is UFC's Preferred Sports Medicine Technology Partner since March 2024.

9m saved
Insight
Article

FAQ

Why Bullish?

This event may enhance brand visibility and credibility in the sports medicine sector.

How important is it?

This initiative showcases Smith+Nephew's commitment and could attract more partnerships and clientele.

Why Long Term?

The partnership with UFC and ongoing education initiatives may create sustained demand.

Related Companies

UFCTKO
Healthcare professionals are invited to register for the livestream option as a courtesy here Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the inaugural Smith+Nephew UFC Combat Sports Medicine Course to be held in Las Vegas, Nevada from February 20-21, 2025. The course will be chaired by Dr. Michael Banffy from the Cedars-Sinai Kerlan-Jobe Institute in Los Angeles, California and features a roster of world-renowned medical experts to discuss current trends and techniques for treating combat sports injuries. Through panel discussions and lectures, attendees will enhance their understanding of sports medicine principles and practices specific to the management, and rehabilitation of injuries in combat sports athletes. Smith+Nephew will also livestream the course in its entirety, making it available as a complimentary option for online registered attendees to view all of the sessions. The popularity of combat sports continues to flourish globally, with hundreds of millions of individuals practicing diverse disciplines including Mixed Martial Arts, Wrestling, Boxing, Judo, Karate, and Tai-Chi among others. In the United States alone, the total number of people participating in Martial Arts grew 31% between 2010 and 2023 to reach a total of 6.6 million.1 “We are extremely proud to be able to help deliver the world’s first medical education course dedicated to combat sports in partnership with the UFC,” said Scott Schaffner, President Sports Medicine, Smith+Nephew. “With the rise in global participation for combat sports, a program designed to treat associated injuries is long overdue, and we’re excited to showcase the leading techniques, technologies and solutions to help these athletes get back to competing at the highest level.” In addition to leading physician faculty, special guest presenters are to include: Chuck ‘The Iceman’ Liddell - Former UFC Light Heavyweight ChampionMax ‘Blessed’ Holloway - Former UFC Featherweight Champion and current UFC BMF ChampionHeather Linden - Senior Director of Physical Therapy for the UFC Performance Institute Smith+Nephew was named the Preferred Sports Medicine Technology Partner of UFC in March 2024. To learn more about the Smith+Nephew UFC Combat Sports Medicine Course and to register for the livestream option, please visit https://bit.ly/3AdUNzS - ends – Media Enquiries Dave Snyder          +1 (978) 749-1440  Smith+Nephew      david.snyder@smith-nephew.com References https://www.statista.com/statistics/191917/participants-in-martial-arts-in-the-us-since-2006/ About Smith+Nephew Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.5 billion in 2023. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise. For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook. About UFC® UFC® is the world’s premier mixed martial arts organization (MMA), with more than 700 million fans and 293  million social media followers. The organization produces more than 40 live events annually in some of the most prestigious arenas around the world while broadcasting to over 975 million TV households across more than 170 countries. UFC’s athlete roster features the world’s best MMA athletes representing more than 80 countries. The organization’s digital offerings include UFC FIGHT PASS®, one of the world’s leading streaming services for combat sports. UFC is part of TKO Group Holdings (NYSE: TKO) and is headquartered in Las Vegas, Nevada. For more information, visit UFC.com and follow UFC at Facebook.com/UFC and @UFC on X, Snapchat, Instagram, and TikTok: @UFC. Forward-looking Statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations. ◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.

Related News